MAP2K7 and melanoma: It was first identified as a key pathway in melanoma through the demonstration that the temporal activation of MEK results in transient activation of ERK, initiating signal transduction and subsequently resulting in activation of downstream modulators of cell proliferation, differentiation, survival, adhesion, angiogenesis, and cell motility [127,128].